Cellevolve Bio develops and commercializes cell therapies using an integrated Cellution clinical development and commercialization platform. The company’s stated goal is to build one of the largest cell therapy pipelines by partnering with innovators and advancing promising assets to market. Cellevolve has assembled a founding leadership team and a global scientific and clinical advisory group to support development and commercialization efforts. It has announced an exclusive manufacturing partnership with Resilience to address manufacturing bottlenecks and enable scalable production. The company is actively recruiting for key leadership roles in Development and Manufacturing to support its commercialization plans. Cellevolve emphasizes translating breakthrough science into therapies that can reach patients quickly and at scale.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2021